Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Byrne

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Australian and New Zealand Journal of Psychiatry|December 1, 1982
The early detection of brain damage in alcoholicsE J Byrne
International Psychogeriatrics|January 1, 1997
Overview of differential diagnosisE J Byrne
BMJ (Clinical Research Ed.)|April 2, 1994
Tetrahydroaminoacridine and Alzheimer's diseaseE J Byrne, T Arie
BMJ (Clinical Research Ed.)|April 28, 1990
Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefitE J Byrne, T Arie
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1991
Transmissible dementiasE J Byrne, J Lowe
BMJ (Clinical Research Ed.)|July 1, 1989
Psychiatric aspects of Parkinson's diseaseR C Baldwin, E J Byrne
BMJ (Clinical Research Ed.)|November 7, 1992
Neuroleptic sensitivity in dementia with cortical Lewy bodiesE J Byrne, A Burns, J Waite
Lancet (London, England)|March 9, 1996
Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromesK K Gnanalingham, E J Byrne, A Thornton
International Psychogeriatrics|January 5, 2002
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleepL E Maclean, C C Collins, E J Byrne
Advances in Neurology|January 1, 1990
Diffuse Lewy body disease: the clinical featuresE J Byrne, G Lennox, J Lowe, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Australian and New Zealand Journal of Psychiatry|December 1, 1982
The early detection of brain damage in alcoholicsE J Byrne
International Psychogeriatrics|January 1, 1997
Overview of differential diagnosisE J Byrne
BMJ (Clinical Research Ed.)|April 2, 1994
Tetrahydroaminoacridine and Alzheimer's diseaseE J Byrne, T Arie
BMJ (Clinical Research Ed.)|April 28, 1990
Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefitE J Byrne, T Arie
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1991
Transmissible dementiasE J Byrne, J Lowe
BMJ (Clinical Research Ed.)|July 1, 1989
Psychiatric aspects of Parkinson's diseaseR C Baldwin, E J Byrne
BMJ (Clinical Research Ed.)|November 7, 1992
Neuroleptic sensitivity in dementia with cortical Lewy bodiesE J Byrne, A Burns, J Waite
Lancet (London, England)|March 9, 1996
Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromesK K Gnanalingham, E J Byrne, A Thornton
International Psychogeriatrics|January 5, 2002
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleepL E Maclean, C C Collins, E J Byrne
Advances in Neurology|January 1, 1990
Diffuse Lewy body disease: the clinical featuresE J Byrne, G Lennox, J Lowe, et al.
Pageof 3